Evidence map›Paper›PMID 38686080›Full record

ArticleIJU case reports2024

A diagnostically challenging case of inflammatory myofibroblastic tumor primary to the peritoneum.

Jurii Karibe, Jun-Ichi Teranishi, Takashi Kawahara, Takeaki Noguchi, Teppei Takeshima, Kimito Osaka, Eita Kumagai, Tomoe Sawazumi, Satoshi Fujii, Hiroji Uemura

Abstract readCase Reports
In one paragraph

Article in IJU case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Inflammatory myofibroblastic tumor of the lung: a comprehensive narrative review of clinical and therapeutic insights.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jurii KaribeDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0001-8146-2861
Jun-Ichi TeranishiDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.
Takashi KawaharaDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0002-7049-3379
Takeaki NoguchiDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0009-0006-5781-260X
Teppei TakeshimaDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0003-2733-5487
Kimito OsakaDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.
Eita KumagaiDepartment of Pathology Yokohama City University Medical Center Yokohama Japan.
Tomoe SawazumiDepartment of Pathology Yokohama City University Medical Center Yokohama Japan.
Satoshi FujiiDepartment of Pathology Yokohama City University Medical Center Yokohama Japan.
Hiroji UemuraDepartment of Urology and Renal Transplantation Yokohama City University Medical Center Yokohama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Inflammatory myofibroblastic tumors are difficult to diagnose because of the lack of specific indicators. We describe a diagnostically challenging case of an inflammatory myofibroblastic tumor primary to the peritoneum. Case presentation: The patient was a 25-year-old male who presented at our hospital with lower abdominal pain. Computed tomography revealed a mass lesion 80 mm in diameter just above the bladder. This was suspected to be a bleeding tumor of the urachus. Since malignancy could not be ruled out, surgery was planned. This revealed a fragile tumor arising from the peritoneum. Following its removal, the tumor was diagnosed by histopathological analysis as an inflammatory myofibroblastic tumor. Conclusion: We describe a case of inflammatory myofibroblastic tumor primary to the peritoneum diagnosed by histopathology. Inflammatory myofibroblastic tumor should be considered in the differential diagnosis of abdominal wall and anterior bladder tumors.

Indexed as

abdominal wallanaplastic lymphoma kinasehistopathological analysisinflammatory myofibroblastic tumorperitoneum

Identifiers

PMID38686080
PMCPMC11056253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.